Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease - Related Studies

Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease

This study has been completed.

Study NCT00471211. Last updated on January 13, 2008. Information provided by Prana Biotechnology Limited

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Alzheimer's Disease

2	Additional conditions recognized in this trial
		Alzheimer Disease

3	More general conditions related to this trial
		Brain Diseases
		Central Nervous System Diseases
		Delirium, Dementia, Amnestic, Cognitive Disorders
		Dementia
		Mental Disorders
		Nervous System Diseases
		Neurodegenerative Diseases
		Tauopathies

4	Interventions listed in this trial
		PBT2

5	Sponsors listed in this trial
		Prana Biotechnology Limited